- Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants
- Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates
- Sitryx regains rights to SYX-1042 itaconate mimetic for chronic autoimmune and inflammatory diseases from Lilly following portfolio reprioritization
- Baculovirus Expression System Market Poised for Significant Growth, Estimate to Hit USD 781.8 Million by 2032 | Coherent Market Insights
- M&A Trends in Pharma Report, Q2 2025 - Deals Fall to $32.9 Billion in Q2 2025, with Oncology Leading at 51 Transactions
- Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
- Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results
- aTyr Pharma Announces Second Quarter 2025 Results and Provides Corporate Update
- Cytokinetics Reports Second Quarter 2025 Financial Results and Provides Business Update
- PharmAla Delivers MDMA to Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License
